Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,137.90
(
1.05%
)
US TECH 100
26,072.80
(
-0.50%
)
Dow Jones
49,490.03
(
0.09%
)
Brent Oil
99.17
(
2.53%
)
Bitcoin
77,424.28
(
-1.04%
)
News Focus
News Focus
Post# of 822499
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

vator

Send PM Follow Ignore
Followers 53
Posts 6781
Boards Moderated 0
Alias Born 02/13/2012

vator

Re: vator post# 589841

Monday, 05/01/2023 7:57:36 AM

Monday, May 01, 2023 7:57:36 AM

Post# of 822499
And if there was a proper CFO these questions could be answered very easily. Analysts will not follow without numbers.

If it is going to be a filing for agnostic tissue at this moment in time that is good strategy. That belongs at the Chairman of the Board. Her other two seats if CEO and CFO should be given up. A CEO with seasoned biotech expertise in immunotherapy. Someone to reassure markets.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NWBO News
More NWBO News